Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Webistes |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Financial Results

Contact us

Sanofi India Limited

54/A, Sir Mathuradas Vasanji Road,
Andheri East,
Mumbai 400 093
India

Board Tel.: (91-22) 28278000
Fax: (91-22) 28370939

Content :

Unaudited Financial Results for the Quarter ended September 30, 2012

SANOFI INDIA LIMITED
Registered Office : 54/A, Sir Mathuradas Vasanji Road,
Andheri East, Mumbai 400 093

Part I

(Rs. Million)

ParticularsQuarter ended 30.09.2012
Unaudited
Quarter ended 30.06.2012
Unaudited
Quarter ended 30.09.2011
Unaudited
Nine Months ended 30.09.2012
Unaudited
Nine Months ended 30.09.2011
Unaudited
Year ended 31.12.2011
(Audited)
1. Income from Operations
(a) Net Sales (net of excise duty)3,9663,7413,12710,9328,91812,297
(b) Other Operating Income194185198582572753
Total income from Operations (net)4,1603,9263,32511,5149,49013,050
2 Expenditure
(a) Cost of Materials Consumed1,3161,4281,1724,0663,6234,916
(b) Purchase of stock in trade4395212521,4388591,353
(c) Changes in inventories of finished goods, work in progress and stock in trade164(98)185(149)(6)(76)
(d) Employee benefits expense4895484151,5271,2611,764
(e) Depreciation and amortisation expense30718661676169311
(f) Other expenses7538206002,2311,8152,579
(g) Total Expenses3,4683,4052,6859,7897,72110,847
3 Profit from Operations before other income and finance costs (1-2)6925216401,7251,7692,203
4 Other Income7282171240535641
5 Profit before finance costs (3+4)7646038111,9652,3042,844
6 Finance costs34-11-4
7 Profit before tax and Exceptional items (5-6)7615998111,9542,3042,840
8 Tax Expense248194263635753928
9 Net Profit for the period before Exceptional items (7-8)5134055481,3191,5511,912
10 Exceptional item (net of tax)------
11 Net Profit for the period after Exceptional items (9+10)5134055481,3191,5511,912
12 Paid-up equity share capital
(Face Value of Rs. 10 per Share)
230230230230230230
13 Reserves excluding Revaluation
Reserves as per balance, sheet of previous accounting year
10,781
14 Earnings Per Share (EPS) before Exceptional items (Rs.)
(Basic and diluted EPS for the period, for the year to date and for the previous year)
22.3017.6123.8357.3567.4383.13
15 Earnings Per Share (EPS) after Exceptional items (Rs.)
(Basic and diluted EPS for the period, for the year to date and for the previous year)
22.3017.6123.8357.3567.4383.13

Part II

ParticularsQuarter ended 30.09.2012
Unaudited
Quarter ended 30.06.2012
Unaudited
Quarter ended 30.09.2011
Unaudited
Nine Months ended 30.09.2012
Unaudited
Nine Months ended 30.09.2011
Unaudited
Year ended 31.12.2011
(Audited)
A. PARTICULARS OF SHAREHOLDING
1 Public Shareholding
- Number of Shares9,121,0359,121,0359,121,0359,121,0359,121,0359,121,035
- Percentage of Shareholding39.60%39.60%39.60%39.60%39.60%39.60%
2 Promoters and Promoter group Shareholding
a) Pledged/Encumbered
- Number of sharesNILNILNILNILNILNIL
- Percentage of shares (as a % of total shareholding of promoter and promoter group)NILNILNILNILNILNIL
- Percentage of shares (as a % of total share capital of the company)NILNILNILNILNILNIL
b) Non-encumbered
- Number of shares13,909,58713,909,58713,909,58713,909,58713,909,58713,909,587
- Percentage of shares (as a % of total
shareholding of promoter and promoter group)
100.00%100.00%100.00%100.00%100.00%100.00%
- Percentage of shares (as a % of total share capital of the company)60.40%60.40%60.40%60.40%60.40%60.40%
Particulars3 Months ended September 30,2012
B. INVESTOR COMPLAINTS
Pending at the beginning of the quarterNIL
Received during the quarter21
Disposed of during the quarter21
Remaining unresolved at the end of the quarterNIL

Notes:

  • The above Results were approved by the Board of Directors of the Company at its Meeting held on October 31, 2012.
  • In accordance with Clause 41 of the Listing Agreement with the Stock Exchanges, the Company's Statutory Auditors have conducted a “Limited Review” of the Financial Results for the quarter ended September 30, 2012.
  • The Board of Directors had declared an Interim Dividend of Rs.4 per Equity share of Rs.10 for the year ending December 31, 2012. The Dividend (including Dividend Distribution Tax) amounted to Rs.107 million. The said dividend was paid on August 16, 2012 through National Electronic Clearing Service/Dividend Warrants.
  • During the quarter ended September 30, 2012, the Company has changed its accounting policy with respect to amortisation of Goodwill. It has been decided to amortise Goodwill on acquisition of business over a period of 10 years starting from the date of acquisition. In the past, Goodwill was not amortised but tested for impairment. As a result of this change, profit after tax for the quarter and nine months ended September 30, 2012 is lower by Rs.78 million, which includes Rs 57 million for the period upto June 30,2012.
  • The profit for the quarter and nine months ended September 30, 2012 has been impacted due to the amortization costs relating to the Brands, Technical know-how and Goodwill acquired in 2011 from Universal Medicare Private Limited and lower interest income as a result of the above investment.
  • The Company has a single business segment namely “Pharmaceutical Business”.
  • The figures for the previous periods have been re-grouped, wherever necessary.



SANOFI INDIA LIMITED

DR. SHAILESH AYYANGAR

MANAGING DIRECTOR

Updated October 31, 2012